Results 51 to 60 of about 4,795 (207)

Effects of cyproheptadine on body weight gain in children with nonorganic failure to thrive in Taiwan: A hospital-based retrospective study.

PLoS ONE, 2021
Failure to thrive (FTT) impairs the expected normal physical growth of children. This study aimed to evaluate the effects of cyproheptadine hydrochloride on growth parameters in prepubertal children with FTT.
Yi-Chun Lin, Hung-Rong Yen, Fuu-Jen Tsai, Chung-Hsing Wang, Lung-Chang Chien, An-Chyi Chen, Ro-Ting Lin   +6 more
doaj   +1 more source

ARFID Triggered by Dysgeusia: A Case Report on Light Therapy, Nutritional Support, and Mirtazapine

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Here, we describe an older man who developed avoidant‐restrictive food intake after an acute onset of dysgeusia that persisted for nearly two years. After initiating a multifactorial treatment approach that included light therapy, nutritional support, and mirtazapine, both the eating disorder and dysgeusia resolved within months.
Aanika Kashyap, Tobi Abibat Saliu, Carrie J. McAdams   +2 more
wiley   +1 more source

Photoirradiation products of cyproheptadine and carbamazepine

, 1984
Cyclobutyl dimer and 10,11-epoxide photoirradiation products of cyproheptadine and carbamazepine have been isolated by preparative tlc and identified by tlc, uv, pmr and mass spectroscopy.
D Sharples, Julie K Robson
core   +1 more source

Identifying patient‐centered outcomes in progressive familial intrahepatic cholestasis: Results from IMPACT

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 2, Page 215-222, August 2026.
Abstract Objectives In rare diseases like progressive familial intrahepatic cholestasis (PFIC), lack of evidence results in treatment variability and strategies for families to engage care teams to understand how variability affects overall health are unknown.
James E. Squires, Gitta H. Lubke, Emily Ventura, Alexandra Perez, Paula M. Hertel, Emily R. Perito, Laura Bull, Melissa Kochanowsky   +7 more
wiley   +1 more source

Effectiveness of cyproheptadine in the prevention of childhood migraine

, 2009
Background Migraine is one of the causes of recurrent headachein childhood. Cyproheptadine is well known as an antihistamine,but there are few studies revealing the drug's effect in pediatricmigraine.Objective To determine the effectiveness of ...
Johannes Saing, Yazid Dimyati, Zulkarnain Zulkarnain, Bistok Saing   +3 more
core   +1 more source

Comparative evaluation of cyproheptadine and mirtazapine in enhancing post-surgical appetite in rabbits following ovariohysterectomy

Letters in Animal Biology
Ovariohysterectomy (OHE) is a fundamental surgical procedure for companion animal population control and the prevention of life-threatening reproductive diseases, significantly improving animal welfare.
Parham Rahmanian, MohammadArad Zandieh, Alireza Jahandideh, Ahmad Asghari   +3 more
doaj   +1 more source

Outcomes in the Management of Pediatric Retrograde Cricopharyngeal Dysfunction

The Laryngoscope, Volume 136, Issue 8, Page 3620-3626, August 2026.
ABSTRACT Objective To review the presentation and treatment outcomes of pediatric patients with retrograde cricopharyngeal dysfunction (RCPD). Methods A retrospective chart review was performed on pediatric patients diagnosed with retrograde cricopharyngeal dysfunction (RCPD) and treated with cricopharyngeal botulinum toxin injection (CPBTI).
Aidan P. Wright, Vivian Jin, Nathaniel B. Hunter, Andrew G. Tritter   +3 more
wiley   +1 more source

Role of cyproheptadine in chronic urticaria not controlled with second-generation antihistamines: a retrospective study [PDF]

Exploration of Immunology
Aim: This retrospective study was performed to evaluate the efficacy and tolerability of cyproheptadine versus montelukast as adjuncts to ongoing second-generation antihistamines in adults with refractory chronic urticaria.
Shambo S. Samajdar, Anupam Das, Saibal Moitra, Shatavisa Mukherjee, Nandini Chatterjee, Shashank R. Joshi   +5 more
doaj   +1 more source

Gastrointestinal Manifestations in Rubinstein‐Taybi Syndrome

American Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1491-1497, July 2026.
ABSTRACT Rubinstein–Taybi syndrome is a rare genetic condition associated with a wide range of physical, cognitive, and developmental impairments, yet its gastrointestinal manifestations remain poorly characterized. Case reports and small series suggest a high prevalence of gastroesophageal reflux, constipation, dysphagia, and nutritional compromise ...
Mohamad Abi Nassif, Ajay Kaul, Lev Dorfman, Khalil El‐Chammas   +3 more
wiley   +1 more source

Cyproheptadine Dependence Associated with an Atypical Somatoform Disorder

, 1987
A case is described of cyproheptadine dependence in a woman with a persistent belief that she was too thin, and diagnosed with an atypical somatoform disorder.
Gary M. Rodin, John L. Craven
core   +1 more source